PMV Pharmaceuticals, Inc.

Harnessing the power of p53 to treat cancer

Add To Watchlist
General Information
Company Name
PMV Pharmaceuticals, Inc.
Founded Year
2013
Location (Offices)
Princeton, United States +1
Founders / Decision Makers
Arnold Levine - Co-Founder Leila Alland - Chief Medical Officer David Mack - Co-Founder, President & CEO Tim Smith - SVP, Head of Corporate Development Thomas Shenk - Co-Founder & Member, Scientific Advisory Board Michael Carulli - Chief Financial Officer
Number of Employees
67
Industries
Biopharma, Biotechnology, Health Care +1
Funding Stage
Series D
Social Media

PMV Pharmaceuticals, Inc. - Company Profile

PMV Pharmaceuticals, Inc. is a biopharmaceutical company founded in 2013 with the slogan "Harnessing the power of p53 to treat cancer." The company is dedicated to revolutionizing cancer treatment by targeting mutant p53, offering unique therapies for patients with tumors harboring these gene mutations. Their last investment round, a $70.00M Series D investment, took place on 03 August 2020. The investors in this round included prominent names such as RA Capital Management, OrbiMed, Boxer Capital, Wellington Management, Avoro Capital, Nextech Invest, and Viking Global Investors. With its headquarters in the United States, PMV Pharmaceuticals is operating at the forefront of the biopharma, biotechnology, healthcare, and medical devices industries.

Taxonomy: Cancer treatment, p53 pathway modulators, Mutant p53 targeting, Biological understanding, Pharmaceutical development, Precision medicine, Oncology research, Drug discovery, Biomolecular therapies

Funding Rounds & Investors of PMV Pharmaceuticals, Inc. (4)

View All
Funding Stage Amount No. Investors Investors Date
Series D $70.00M 7
RA Capital Management, investor in PMV Pharmaceuticals, Inc.'s Series D round OrbiMed, investor in PMV Pharmaceuticals, Inc.'s Series D round Boxer Capital, investor in PMV Pharmaceuticals, Inc.'s Series D round Wellington Management, investor in PMV Pharmaceuticals, Inc.'s Series D round Avoro Capital, investor in PMV Pharmaceuticals, Inc.'s Series D round Nextech Invest, investor in PMV Pharmaceuticals, Inc.'s Series D round Viking Global Investors, investor in PMV Pharmaceuticals, Inc.'s Series D round
03 Aug 2020
Series C $62.00M 3
InterWest Partners, investor in PMV Pharmaceuticals, Inc.'s Series C round Nextech Invest, investor in PMV Pharmaceuticals, Inc.'s Series C round
OUP (Osage University Partners) 		13 Nov 2019
Series B $74.00M - 22 Feb 2017
Series A $30.00M - 02 Dec 2014

Latest News of PMV Pharmaceuticals, Inc.

View All

No recent news or press coverage available for PMV Pharmaceuticals, Inc..

Similar Companies to PMV Pharmaceuticals, Inc.

View All
Ascentage Pharma - Similar company to PMV Pharmaceuticals, Inc.
Ascentage Pharma
Cleara Biotech B.V. - Similar company to PMV Pharmaceuticals, Inc.
Cleara Biotech B.V. Targeting cellular senescence to extend human healthspan at old age and to counteract late stage cancer
PHusis Therapeutics - Similar company to PMV Pharmaceuticals, Inc.
PHusis Therapeutics
Elicio Therapeutics - Similar company to PMV Pharmaceuticals, Inc.
Elicio Therapeutics Orchestrating the immune response to defeat cancer & infectious diseases
Kura Oncology, Inc. - Similar company to PMV Pharmaceuticals, Inc.
Kura Oncology, Inc. Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
Circle Decoration Circle Decoration

Want to dive deeper into PMV Pharmaceuticals, Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now